Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Fimasartan

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,129Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Boryung Pharmaceutical Co., Ltd
    South Korea
    		 Boryeong Co., Ltd. 1689-2-ND Pimasartan potassium trihydrate 2016-04-20 Boryeong Co., Ltd. South Korea 107, 109 Neungan-ro, Danwon-gu, Ansan-si, Gyeonggi-do
    28/09/2024 Boryung Pharmaceutical Co., Ltd
    South Korea
    		 Boryeong Co., Ltd. 1689-1-ND Pimasartan potassium trihydrate 2010-08-31 Boryeong Co., Ltd. South Korea 107, 109 Neungan-ro, Danwon-gu, Ansan-si, Gyeonggi-do